SWTX logo

SpringWorks Therapeutics, Inc. Common Stock


SWTX: SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.


Show SWTX Financials

Consumer Interest
SEC Filings

Recent trades of SWTX by members of U.S. Congress

Recently reported changes by institutional investors

Quarterly net insider trading by SWTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Dispersible formulations of n-((r)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof Feb. 07, 2023
  • Patent Title: Solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof Aug. 30, 2022
  • Patent Title: Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof Aug. 10, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of SWTX in WallStreetBets Daily Discussion


Recent insights relating to SWTX

CNBC Recommendations

Recent picks made for SWTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SWTX

Corporate Flights

Flights by private jets registered to SWTX